The Rivaroxaban Market has been witnessing accelerated growth due to increasing cases of deep vein thrombosis, pulmonary embolism, and atrial fibrillation. Enhanced awareness among physicians and patients about the benefits of oral anticoagulants is encouraging wider adoption. Additionally, the development of safer, once-daily dosing regimens is improving patient compliance and treatment...